Effect of Depressin Screening and Care Program at Community Health Center
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01626703 |
Recruitment Status
:
Completed
First Posted
: June 25, 2012
Last Update Posted
: March 10, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Depression affect between 5% and 10% of older adults seen in the primary care setting.Late-life depression is often chronic or recurrent and is associated with substantial suffering, functional impairment, and diminished health-related quality of life.Depressed, older primary care patients are frequent users of general medical services and may have poor adherence to medical treatments.They are also at increased risk of death from suicide and medical illnesses. The aim of this study is to examine whether depression screening and health care practitioner feedback are increased depression treatment rate.
Depression screening is provided 60 or more who visited community health care center with a 15-item Geriatric Depression Scale.GDS scores of 10 or more were classified depression positive. Intervention group participants received twice remind calls from primary care nurse.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Depression Screening Elderly | Other: Reminding call | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 86 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Primary Purpose: | Screening |
Study Start Date : | June 2012 |
Actual Primary Completion Date : | December 2012 |
Actual Study Completion Date : | March 2013 |

Arm | Intervention/treatment |
---|---|
Experimental: intervention
remiding call
|
Other: Reminding call |
No Intervention: Control
No intervention
|
- Reuptake rate [ Time Frame: 12 weeks ]
- reduced depressive symptoms [ Time Frame: 12 weeks ]Geriatric Depression Scale Short Form (SGDS)
- changed perceived heath status [ Time Frame: 12 weeks ]Visual Analogue Scale (VAS)

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 60 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- 60 or more
- 10 or more in GDS scor
Exclusion Criteria:
- severe cognitive problem

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01626703
Korea, Republic of | |
Chungju community health care center | |
Chungju, Choongbuk, Korea, Republic of, 123456 |
Responsible Party: | Hyeon Woo Yim, professor, National Clinical Research Coordination Center, Seoul, Korea |
ClinicalTrials.gov Identifier: | NCT01626703 History of Changes |
Other Study ID Numbers: |
A102065_2012_2 |
First Posted: | June 25, 2012 Key Record Dates |
Last Update Posted: | March 10, 2016 |
Last Verified: | March 2016 |